Related Experiment Video
Updated: Jan 13, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Alstonia boonei Promising Source of Anti-inflammatory, Antimalarial, and Ulcer Protective Agents-A Review
1University Institute of Pharma Sciences, Chandigarh University, Gharuan Mohali, 140413, India.
Abstract:
Alstonia boonei (Apocynaceae) is a medicinal plant widely used in West and Central Africa to manage malaria, fever, intestinal worms, rheumatism, and hypertension. This review compiles evidence on its traditional uses, phytoconstituents, pharmacological activities, and formulations, to encourage future research into its therapeutic potential for modern health challenges. Literature review confirms notable anti-inflammatory, antimalarial, and ulcer-protective activities, while additional studies highlight its potential in antioxidant, anti-diabetic, neuroprotective, antiobesity, cytochrome P450 (CYP) enzyme inhibitory, anti-cataract, anticancer, and antibacterial effects. Phytochemical analysis reveals the presence of diverse bioactive compounds, including alkaloids, saponins, tannins, terpenes, phenolic compounds, and glycosides, which may act individually or synergistically to yield broad pharmacological actions. Recent experimental data reinforce its therapeutic relevance, positioning Alstonia boonei as a promising source of natural products. The wide spectrum of biological activities, coupled with the structural diversity of its phytoconstituents, underscores its importance as a valuable medicinal resource. In conclusion, Alstonia boonei shows significant potential for the development of anti-inflammatory, antimalarial, and ulcerprotective bioactive agents, justifying further scientific exploration and drug discovery efforts.
More Related Videos
04:47Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
Published on: October 27, 2023
09:16Author Spotlight: Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Physical Properties of Amines
Fungal Phylum Ascomycota
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists